Research and Discussion on Risk Management in the Newly-revised Measures for the Supervision and Administration of Pharmaceutical Production

Liao Huijun, Xu Weiguo, Du Chuanlong, Ren Feng

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 624-630.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 624-630. DOI: 10.16153/j.1002-7777.2021.06.003
Supervision Administration

Research and Discussion on Risk Management in the Newly-revised Measures for the Supervision and Administration of Pharmaceutical Production

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(6): 624-630 https://doi.org/10.16153/j.1002-7777.2021.06.003

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/